Stevens Capital Management’s Charles River Laboratories CRL Stock Holding History

Stevens Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,316	Closed	-$439K	–	638
2019 Q3	$439K	Buy	+3,316	New	+$445K	0.04%	379
2019 Q1	–	Sell	-5,412	Closed	-$613K	–	716
2018 Q4	$613K	Buy	+5,412	New	+$678K	0.03%	464
2017 Q4	–	Sell	-36,563	Closed	-$3.95M	–	864
2017 Q3	$3.95M	Buy	36,563 +28,315	+343%	+$2.91M	0.15%	192
2017 Q2	$834K	Buy	8,248 +2,503	+44%	+$230K	0.03%	472
2017 Q1	$517K	Buy	+5,745	New	+$488K	0.02%	569
2016 Q4	–	Sell	-11,063	Closed	-$922K	–	908
2016 Q3	$922K	Buy	+11,063	New	+$927K	0.04%	443
2016 Q2	–	Sell	-10,330	Closed	-$784K	–	937
2016 Q1	$784K	Buy	+10,330	New	+$765K	0.03%	478
2015 Q4	–	Sell	-9,481	Closed	-$602K	–	956
2015 Q3	$602K	Sell	9,481 -4,228	-31%	-$304K	0.03%	484
2015 Q2	$964K	Buy	+13,709	New	+$1.01M	0.03%	435
2015 Q1	–	Sell	-7,013	Closed	-$446K	–	1018
2014 Q4	$446K	Buy	+7,013	New	+$440K	0.02%	610
2014 Q3	–	Sell	-32,599	Closed	-$1.75M	–	1035
2014 Q2	$1.75M	Buy	+32,599	New	+$1.79M	0.05%	393
2013 Q4	–	Sell	-24,766	Closed	-$1.15M	–	1037
2013 Q3	$1.15M	Sell	24,766 -11,994	-33%	-$550K	0.03%	453
2013 Q2	$1.51M	Buy	+36,760	New	+$1.57M	0.05%	375

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Stevens Capital Management's CRL Position: Q4 2019 in Review

Stevens Capital Management sold out of Charles River Laboratories (CRL) in Q4 2019, closing a stake of 3,316 shares — an estimated $439K sold.

Stevens Capital Management first reported a position in CRL in Q2 2013 and held it in 13 quarters. The position peaked at $3.95M in Q3 2017. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

Stevens Capital Management reported no remaining Charles River Laboratories position as of Q4 2019 after selling out during the quarter.
Stevens Capital Management sold 3,316 Charles River Laboratories shares in Q4 2019, an estimated $439K.
Stevens Capital Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 13 quarters.
Stevens Capital Management's Charles River Laboratories position peaked at $3.95M in Q3 2017.
413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on Stevens Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.